Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Cannabidiol in Anandamide-Related Improvement in Alexithymia and Health Outcomes

NCT05832281 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05832281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Cannabidiol in Anandamide-Related Improvement in Alexithymia and Health Outcomes
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Terminated
Start date
March 12, 2024
Completion date
August 31, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alexithymia, hiv